Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1998048836) ANTI-$i(HELICOBACTER) VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/048836 International Application No.: PCT/FR1998/000875
Publication Date: 05.11.1998 International Filing Date: 30.04.1998
Chapter 2 Demand Filed: 25.11.1998
IPC:
A61K 39/39 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
39
characterised by the immunostimulating additives, e.g. chemical adjuvants
Applicants:
MERIEUX ORAVAX [FR/FR]; 58, avenue Leclerc F-69007 Lyon, FR (AL, AM, AT, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BY, CA, CF, CG, CH, CI, CM, CN, CU, CY, CZ, DE, DK, EE, ES, FI, FR, GA, GB, GE, GH, GM, GN, GR, HU, IE, IL, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MC, MD, MG, MK, ML, MN, MR, MW, MX, NE, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SN, SZ, TD, TG, TJ, TM, TR, TT, UA, UG, UZ, VN, ZW)
GUY, Bruno [FR/FR]; FR (UsOnly)
HAENSLER, Jean [FR/FR]; FR (UsOnly)
Inventors:
GUY, Bruno; FR
HAENSLER, Jean; FR
Agent:
AYROLES, Marie-Pauline; Pasteur Mérieux Sérums & Vaccins Direction Propriété Industrielle 58, avenue Leclerc F-69007 Lyon, FR
Priority Data:
97/0560830.04.1997FR
97/1573208.12.1997FR
Title (EN) ANTI-$i(HELICOBACTER) VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT
(FR) COMPOSITION VACCINALE ANTI-$i(HELICOBACTER) COMPRENANT UN ADJUVANT DE TYPE TH1
Abstract:
(EN) The invention concerns the use of an immunogenic agent derived from $i(Helicobacter), associated with an adjuvant such as QS-21, DC-chol or Bay R1005, for making a pharmaceutical composition designed to induce an immune response of the T helper 1 type (Th1), for preventing or treating $i(Helicobacter) infection in a mammal.
(FR) L'invention a pour objet l'usage d'un agent immunogène dérivé d'$i(Helicobacter), en association avec un adjuvant tel que le QS-21, le DC-chol ou le Bay R1005, dans la fabrication d'une composition pharmaceutique destinée à l'induction d'une réponse immune de type T helper 1 (Th1) à l'encontre d'$i(Helicobacter), pour prévenir ou traiter une infection à $i(Helicobacter) chez un mammifère.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: French (FR)
Filing Language: French (FR)
Also published as:
KR1020010020418EP0979100JP2002505665 CA2287976AU1998076584